RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Study Purpose

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational [Patient Registry]
Eligible Ages N/A and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy.
  • - Willingness to sign an Informed Consent Document or verbally agree to participation.

Exclusion Criteria:

- There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT01885299
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

The Radiosurgery Society
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Anand Mahadevan, MD
Principal Investigator Affiliation The Radiosurgery Society
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Neoplasms, Arteriovenous Malformation of Central Nervous System, Trigeminal Neuralgia
Additional Details

The Registry is designed to help SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) users to understand utilization of and key treatment outcomes for these treatment approaches. Some of the objectives include: Allow participants to record information about usage of SRS/SBRT in everyday practice, including patient characteristics and disease information, treatment plans and outcomes Provide participants with ready access to data for publication of their own experience and as a tool for establishing collaborations with other participating sites Facilitate quality improvement efforts for individual treatment providers Understand the effectiveness of different treatment plans for different types of lesions, diseases and treatments.The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA for prostate cancer); the Registry also provides individual participants the ability to add additional outcomes for each and any condition of specific interest to their institutions. The Registry is hosted by Vision Tree, Inc who is an independent vendor of electronic registries; they are responsible for HIPAA compliance, including all security mechanisms. Patients will be enrolled prospectively. Some retrospective patient data is likely to be included in order to capture both short and longer term outcomes data.

Arms & Interventions

Arms

: Patients being treated by SRS/SBRT

Patients with a condition being considered for treatment by SRS/SBRT

Interventions

Radiation: - SRS/SBRT

Intervention varies by condition being treated.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Penrose Cancer Center, Colorado Springs 5417598, Colorado 5417618

Status

Enrolling by invitation

Address

Penrose Cancer Center

Colorado Springs 5417598, Colorado 5417618, 80907

Site Contact

[email protected]

Miami 4164138, Florida 4155751

Status

Recruiting

Address

Sylvester Comprehensive Cancer Center, University of Miami

Miami 4164138, Florida 4155751, 33146

Site Contact

Gregory A Azzam, MD

[email protected]

Southeast Georgia Health System, Brunswick 4184845, Georgia 4197000

Status

Enrolling by invitation

Address

Southeast Georgia Health System

Brunswick 4184845, Georgia 4197000, 31520

Site Contact

[email protected]

Henry Ford Health System, Detroit 4990729, Michigan 5001836

Status

Recruiting

Address

Henry Ford Health System

Detroit 4990729, Michigan 5001836, 48202

Site Contact

Celina Kirsch, P.A.

[email protected]

313-640-2345

Egg Harbor 8766331, New Jersey 5101760

Status

Enrolling by invitation

Address

AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute

Egg Harbor 8766331, New Jersey 5101760, 08234

Site Contact

[email protected]

Riverview Medical Center, Red Bank 5103159, New Jersey 5101760

Status

Enrolling by invitation

Address

Riverview Medical Center

Red Bank 5103159, New Jersey 5101760, 07701

Site Contact

[email protected]

Toms River 4504476, New Jersey 5101760

Status

Enrolling by invitation

Address

NJ Cyberknife at Community Medical Center

Toms River 4504476, New Jersey 5101760, 08755

Site Contact

[email protected]

Montefiore Medical Center, The Bronx 5110266, New York 5128638

Status

Enrolling by invitation

Address

Montefiore Medical Center

The Bronx 5110266, New York 5128638, 10502

Site Contact

[email protected]

Geisinger Health System, Danville 5186327, Pennsylvania 6254927

Status

Enrolling by invitation

Address

Geisinger Health System

Danville 5186327, Pennsylvania 6254927, 17822

Site Contact

[email protected]

Philadelphia CyberKnife, Philadelphia 4560349, Pennsylvania 6254927

Status

Enrolling by invitation

Address

Philadelphia CyberKnife

Philadelphia 4560349, Pennsylvania 6254927, 19083

Site Contact

[email protected]

Pottstown Memorial Medical Center, Pottstown 5207069, Pennsylvania 6254927

Status

Enrolling by invitation

Address

Pottstown Memorial Medical Center

Pottstown 5207069, Pennsylvania 6254927, 19464

Site Contact

[email protected]

Cyberknife at Erlanger, Chattanooga 4612862, Tennessee 4662168

Status

Enrolling by invitation

Address

Cyberknife at Erlanger

Chattanooga 4612862, Tennessee 4662168, 37403

Site Contact

[email protected]

St. Mary's Medical Center, Huntington 4809537, West Virginia 4826850

Status

Enrolling by invitation

Address

St. Mary's Medical Center

Huntington 4809537, West Virginia 4826850, 25701

Site Contact

[email protected]

Stay Informed & Connected